
Chinmedomics: A Powerful Approach Integrating Metabolomics with Serum Pharmacochemistry to Evaluate the Efficacy of Traditional Chinese Medicine
Ai-Hua Zhang, Hui Sun, Guang-Li Yan, Ying Han, Qi-Qi Zhao, Xi-Jun Wang
Chinmedomics: A Powerful Approach Integrating Metabolomics with Serum Pharmacochemistry to Evaluate the Efficacy of Traditional Chinese Medicine
Evaluation of the efficacy of traditional Chinese medicines (TCMs) is an important prerequisite for discovering effective substances, lead compounds, and quality markers (Q markers). At present, there is an urgent need to develop a biological language that can act as abridge for the scientific elaboration of the efficacy of TCMs, and to further highlight the significant value of TCM. Chinese medicinal syndromes and formulae are two essential parts of TCM that directly relate to its efficacy. Syndromes and formulae have been taken as the research objects. The serum pharmacochemistry of the TCM approach with metabolomics were integrated to establish an innovative chinmedomics strategy, which is able to explore syndrome biomarkers and evaluate TCM efficacy in order to discover effective substances from TCMs. A great deal of concrete work in chinmedomics has already performed to bridge the gap between Chinese and Western medicine, and to provide a powerful approach to enhance the scientific value of TCM theory and clinical practice. This article summarizes the application of chinmedomics in identifying the candidate biomarkers of a syndrome and revealing the efficacy of the related formula. We also highlight the discovery of lead compounds and Q markers from TCMs.
Chinmedomics / Serum pharmacochemistry of TCM / Efficacy / Metabolomics / Syndrome / Biomarkers / Quality markers
[[1]] |
Harvey A.L., Edrada-Ebel R., Quinn R.J.. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015; 14(2): 111-129.
|
[[2]] |
Zhang A., Sun H., Wang X.. Recent advances in natural products from plants for treatment of liver diseases. Eur J Med Chem. 2013; 63: 570-577.
|
[[3]] |
Hu J., Pang W.S., Han J., Zhang K., Zhang J.Z., Chen L.D.. Gualou Guizhi decoction reverses brain damage with cerebral ischemic stroke, multi-component directed multi-target to screen calcium-overload inhibitors using combination of molecular docking and protein-protein docking. J Enzyme Inhib Med Chem. 2018; 33(1): 115-125.
|
[[4]] |
Chen L., Wang X., Liu Y., Di X.. Dual-target screening of bioactive components from traditional Chinese medicines by hollow fiber-based ligand fishing combined with liquid chromatography-mass spectrometry. J Pharm Biomed Anal. 2017; 143: 269-276.
|
[[5]] |
Cui L., Cai Y., Cheng W., Liu G., Zhao J., Cao H.,
|
[[6]] |
Cao H., Zhang A., Zhang H., Sun H., Wang X.. The application of metabolomics in traditional Chinese medicine opens up a dialogue between Chinese and Western medicine. Phytother Res. 2015; 29(2): 159-166.
|
[[7]] |
Zhang Y., Liu Y., Li Y., Zhao X., Zhuo L., Zhou A.,
|
[[8]] |
Wang X., Zhang A., Sun H.. Future perspectives of Chinese medical formulae: chinmedomics as an effector. OMICS. 2012; 16(7–8): 414-421.
|
[[9]] |
Zhang A.H., Sun H., Yan G.L., Wang P., Han Y., Wang X.J.. Chinmedomics: a new strategy for research of traditional Chinese medicine. China J Chin Mater Med. 2015; 40(4): 569-576. Chinese
|
[[10]] |
Liu Q., Zhao H.W., Zhang A.H., Sun H., Zhao X.H., Nan Y.,
|
[[11]] |
Wang X., Zhang A., Sun H., Wang P.. Systems biology technologies enable personalized traditional Chinese medicine: a systematic review. Am J Chin Med. 2012; 40(6): 1109-1122.
|
[[12]] |
Zhang A., Sun H., Yan G., Cheng W., Wang X.. Systems biology approach opens door to essence of acupuncture. Complement Ther Med. 2013; 21(3): 253-259.
|
[[13]] |
Zhang N.D., Han T., Huang B.K., Rahman K., Xu H.T., Jiang Y.P.,
|
[[14]] |
Chen M., Yang F., Yang X., Lai X., Gao Y.. Systematic understanding of mechanisms of a Chinese herbal formula in treatment of metabolic syndrome by an integrated pharmacology approach. Int J Mol Sci. 2016; 17(12): E2114.
|
[[15]] |
Xiang Z., Sun H., Cai X., Chen D., Zheng X.. The study on the material basis and the mechanism for anti-renal interstitial fibrosis efficacy of rhubarb through integration of metabonomics and network pharmacology. Mol Biosyst. 2015; 11(4): 1067-1078.
|
[[16]] |
Li X.N., Zhang A., Sun H., Song Y., Zou D., Wang X.. Rapid discovery of absorbed constituents and metabolites in rat plasma after the oral administration of Zi Shen Wan using high-throughput UHPLC-MS with a multivariate analysis approach. J Sep Sci. 2016; 39(24): 4700-4711.
|
[[17]] |
Chu H., Zhang A., Han Y., Lu S., Kong L., Han J.,
|
[[18]] |
Sun H., Chen X., Zhang A., Sakurai T., Jiang J., Wang X.. Chromatographic fingerprinting analysis of Zhizhu Wan preparation by high-performance liquid chromatography coupled with photodiode array detector. Pharmacogn Mag. 2014; 10(40): 470-476.
|
[[19]] |
Zhang A., Zou D., Yan G., Tan Y., Sun H., Wang X.. Identification and characterization of the chemical constituents of Simiao Wan by ultra high performance liquid chromatography with mass spectrometry coupled to an automated multiple data processing method. J Sep Sci. 2014; 37(14): 1742-1747.
|
[[20]] |
Wang X.J.. Progress and future developing of the serum pharmacochemistry of traditional Chinese medicine. China J Chin Mater Med. 2006; 31(10): 789-792. 835. Chinese
|
[[21]] |
Wang X., Lv H., Sun H., Liu L., Yang B., Sun W.,
|
[[22]] |
Zhang A., Yan G., Zhou X., Wang Y., Han Y., Guan Y.,
|
[[23]] |
Wang X., Zhang A., Zhou X., Liu Q., Nan Y., Guan Y.,
|
[[24]] |
Zhang A., Sun H., Wang Z., Sun W., Wang P., Wang X.. Metabolomics: towards understanding traditional Chinese medicine. Planta Med. 2010; 76(17): 2026-2035.
|
[[25]] |
Yu J., Kong L., Zhang A., Han Y., Liu Z., Sun H.,
|
[[26]] |
Sun H., Zhang A., Wang X.. Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine. Phytother Res. 2012; 26(10): 1466-1471.
|
[[27]] |
Wang X., Sun H., Zhang A., Sun W., Wang P., Wang Z.. Potential role of metabolomics approaches in the area of traditional Chinese medicine: as pillars of the bridge between Chinese and Western medicine. J Pharm Biomed Anal. 2011; 55(5): 859-868.
|
[[28]] |
Wang X., Zhang A., Han Y., Wang P., Sun H., Song G.,
|
[[29]] |
Sun H., Zhang A., Yan G., Piao C., Li W., Sun C.,
|
[[30]] |
Liu Q., Zhang A., Wang L., Yan G., Zhao H., Sun H.,
|
[[31]] |
Yan G.L., Sun H., Zhang A.H., Han Y., Wang P., Wu X.H.,
|
[[32]] |
Zhao W., Shang Z., Li Q., Huang M., He W., Wang Z.,
|
[[33]] |
Yan G.L., Zhang A.H., Sun H., Han Y., Shi H., Zhou Y.,
|
[[34]] |
Cao H., Zhang A., Zhang F.M., Wang Q.Q., Zhang H., Song Y.H.,
|
[[35]] |
Sun H., Dong W., Zhang A., Wang W., Wang X.. Pharmacokinetics study of multiple components absorbed in rat plasma after oral administration of Stemonae radix using ultra-performance liquid–chromatography/mass spectrometry with automated MetaboLynx software analysis. J Sep Sci. 2012; 35(24): 3477-3485.
|
[[36]] |
Wang X, Zhang A, Sun H, editors. Chinmedomics: the integration of serum pharmacochemistry and metabolomics to elucidate the scientific value of traditional Chinese medicine. Cambridge: Academic Press; 2015.
|
[[37]] |
Wang X., Zhang A., Sun H., Yan G.. Chinmedomics: newer theory and application. Chin Herb Med. 2016; 8(4): 299-307.
|
[[38]] |
Wang X., Zhang A., Sun H., Yan G.. Origin of chinmedomics. In: Chinmedomics: the integration of serum pharmacochemistry and metabolomics to elucidate the scientific value of traditional Chinese medicine. Cambridge: Academic Press; 2015. p. 1-15.
|
[[39]] |
Wang X., Zhang A., Sun H., Han Y.. Methods and protocols of chinmedomics. In:
|
[[40]] |
Chu H., Zhang A., Han Y., Wang X.. Metabolomics and its potential in drug discovery and development from TCM. World J Tradit Chin Med. 2015; 1(4): 26-32.
|
[[41]] |
Wang X., Zhang A., Sun H., Han Y., Yan G.. Discovery and development of innovative drug from traditional medicine by integrated chinmedomics strategies in the post-genomic era. TrAC Trends Anal Chem. 2016; 76: 86-94.
|
[[42]] |
Dong H., Yan G.L., Han Y., Sun H., Zhang A.H., Li X.N.,
|
[[43]] |
Zhao Q., Zhang A., Zong W., An N., Zhang H., Luan Y.,
|
[[44]] |
Wang X., Zhang A., Yan G., Han Y., Sun H.. UHPLC-MS for the analytical characterization of traditional Chinese medicines. TrAC Trends Anal Chem. 2014; 63: 180-187.
|
[[45]] |
Zhang T., Zhang A., Qiu S., Yang S., Wang X.. Current trends and innovations in bio-analytical techniques of metabolomics. Crit Rev Anal Chem. 2016; 46(4): 342-351.
|
[[46]] |
Ren J., Zhang A., Kong L., Wang X.. Advances in mass spectrometry-based metabolomics for investigation of metabolites. RSC Adv. 2018; 8(40): 22335-22350.
|
[[47]] |
Han Y., Zhang A.H., Zhang Y.Z., Sun H., Meng X.C., Wang X.J.. Chemical metabolomics for investigating the protective effectiveness of Acanthopanax senticosus Harms leaf against acute promyelocytic leukemia. RSC Adv. 2018; 8(22): 11983-11990.
|
[[48]] |
Xie J., Zhang A., Sun H., Yan G., Wang X.. Recent advances and effective strategies in the discovery and applications of natural products. RSC Adv. 2018; 8(2): 812-824.
|
[[49]] |
Song Q., Zhang A.H., Yan G.L., Liu L., Wang X.J.. Technological advances in current metabolomics and its application in tradition Chinese medicine. RSC Adv. 2017; 7(84): 53516-53524.
|
[[50]] |
Sun H., Liu J., Zhang A., Zhang Y., Meng X., Han Y.,
|
[[51]] |
Liu C., Zhang A., Yan G.L., Shi H., Sun H., Han Y.,
|
[[52]] |
Zhang A., Sun H., Yan G., Wang P., Wang X.. Mass spectrometry-based metabolomics: applications to biomarker and metabolic pathway research. Biomed Chromatogr. 2016; 30(1): 7-12.
|
[[53]] |
Zhang A., Sun H., Yan G., Wang P., Wang X.. Metabolomics for biomarker discovery: moving to the clinic. Biomed Res Int. 2015; 2015: 354671.
|
[[54]] |
Li X., Sun H., Zhang A., Liu Z., Zou D., Song Y.,
|
[[55]] |
Zhang A., Fang H., Wang Y., Yan G., Sun H., Zhou X.,
|
[[56]] |
Zhao Q., Zhang A., Zong W., An N., Zhang H., Luan Y.,
|
[[57]] |
Zhang A., Sun H., Wang X.. Emerging role and recent applications of metabolomics biomarkers in obesity diseases research. RSC Adv. 2017; 7(25): 14966-14973.
|
[[58]] |
Xie J., Zhang A., Wang X.. Metabolomic applications in hepatocellular carcinoma: toward the exploration of therapeutics and diagnosis through small molecules. RSC Adv. 2017; 7(28): 17217-17226.
|
[[59]] |
Zhang A., Sun H., Yan G., Wang X.. Recent developments and emerging trends of mass spectrometry for herbal ingredients analysis. TrAC Trends Anal Chem. 2017; 94: 70-76.
|
[[60]] |
Liu X.Y., Zhang A.H., Fang H., Li M.X., Song Q., Su J.,
|
[[61]] |
Fang H., Zhang A., Yu J., Wang L., Liu C., Zhou X.,
|
[[62]] |
Zhou X.H., Zhang A.H., Wang L., Tan Y.L., Guan Y., Han Y.,
|
[[63]] |
Zhang A., Liu Q., Zhao H., Zhou X., Sun H., Nan Y.,
|
[[64]] |
Wang P., Sun H., Lv H., Sun W., Yuan Y., Han Y.,
|
[[65]] |
Wang X., Wang Q., Zhang A., Zhang F., Zhang H., Sun H.,
|
[[66]] |
Sun H., Yang L., Li M.X., Fang H., Zhang A.H., Song Q.,
|
[[67]] |
Wang X., Yang B., Zhang A., Sun H., Yan G.. Potential drug targets on insomnia and intervention effects of Jujuboside A through metabolic pathway analysis as revealed by UPLC/ESI-SYNAPT-HDMS coupled with pattern recognition approach. J Proteomics. 2012; 75(4): 1411-1427.
|
[[68]] |
Zhang A., Sun H., Han Y., Yuan Y., Wang P., Song G.,
|
[[69]] |
Zhang A., Sun H., Qiu S., Wang X.. Advancing drug discovery and development from active constituents of Yinchenhao Tang, a famous traditional Chinese medicine formula. Evid Based Complement Alternat Med. 2013; 2013: 257909.
|
[[70]] |
Wang P., Lv H., Zhang A., Sun H., Yan G., Han Y.,
|
[[71]] |
Wang H., Sun H., Zhang A., Li Y., Wang L., Shi H.,
|
[[72]] |
Nan Y., Zhou X., Liu Q., Zhang A., Guan Y., Lin S.,
|
[[73]] |
Yang B., Zhang A., Sun H., Dong W., Yan G., Li T.,
|
[[74]] |
Zhang A.H., Yu J.B., Sun H., Kong L., Wang X.Q., Zhang Q.Y.,
|
[[75]] |
Lu S., Han Y., Chu H., Kong L., Zhang A., Yan G.,
|
[[76]] |
Han Y., Wu F., Zhang A., SunH Wei W, Wang X.,
|
[[77]] |
Wang X., Zhang S., Zhang A., Yan G., Wu X., Han Y.,
|
[[78]] |
Yan G.L., Zhang A.H., Sun H., Han Y., Shi H., Zhou Y.,
|
[[79]] |
Gao H.L., Zhang A.H., Yu J.B., Sun H., Kong L., Wang X.Q.,
|
[[80]] |
Wu X.H., Zhao C., Zhang A.H., Zhang J.Q., Wang X., Sun X.L.,
|
[[81]] |
Sun H, Zhang A, Yang L, Li M, Fang H, Xie J, et al. High-throughput chinmedomics strategy for discovering the quality-markers and potential targets for Yinchenhao decoction. Phytomedicine. In press. http://doi.org/10.1016/j.phymed.2018.04.015.
|
[[82]] |
Zhang A., Sun H., Wang X.. Mass spectrometry-driven drug discovery for development of herbal medicine. Mass Spectrom Rev. 2018; 37(3): 307-320.
|
[[83]] |
Li X.N., Zhang A., Wang M., Sun H., Liu Z., Qiu S.,
|
[[84]] |
Jiang Z, Yang J, Wang Y. Discrimination and identification of Q-markers based on ‘Spider-web’ mode for quality control of traditional Chinese medicine. Phytomedicine. Epub 2017 Dec 28.
|
[[85]] |
Yang W., Zhang Y., Wu W., Huang L., Guo D., Liu C.. Approaches to establish Q-markers for the quality standards of traditional Chinese medicines. Acta Pharm Sin B. 2017; 7(4): 439-446.
|
[[86]] |
Wang X, Zhang A, Kong L, Yu J, Gao H, Liu Z, et al. Rapid discovery of quality-markers from Kaixin San using chinmedomics analysis approach. Phytomedicine. In press. http://doi.org/10.1016/j.phymed.2017.12.014.
|
[[87]] |
Zhang A., Sun H., Wang X.. Potentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicine. Phytother Res. 2014; 28(4): 526-533.
|
[[88]] |
Liu C.X.. Chinmedomics builds a bridge from traditional to modern research of traditional Chinese medicine. Chin Herb Med. 2016; 8(4): 297-298.
|
[[89]] |
Sang X.X., Wang Z.X., Liu S.Y., Wang R.L.. Relationship between traditional Chinese medicine (TCM) constitution and TCM syndrome in the diagnosis and treatment of chronic diseases. Chin Med Sci J. 2018; 33(2): 114-119.
|
[[90]] |
Li Q., Zhang A., Sun H., Wang X.. Pharmacokinetics applications of traditional Chinese medicines. World J Tradit Chin Med. 2016; 2(1): 42-47.
|
[[91]] |
Ma L., Wang B., Long Y., Li H.. Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis. Front Med. 2017; 11(2): 191-202.
|
This work was supported by grants from the Key Program of National Natural Science Foundation of China (81830110, 81430093, 81373930, 81673586, 81302905, and 81503386), the National Key Subject of Drug Innovation (2015ZX09101043-005 and 2015ZX09101043-011), the TCM State Administration Subject of Public Welfare (2015468004), the University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (UNPYSCT-2015118), and the Young Talent Lift Engineering Project of China Association of Traditional Chinese Medicine (QNRC2-B06).
Ai-Hua Zhang, Hui Sun, Guang-Li Yan, Ying Han, Qi-Qi Zhao, and Xi-Jun Wang declare that they have no conflict of interest or financial conflicts to disclose.
/
〈 |
|
〉 |